Feb 05, 2025 14:01
NVCT - Nuvectis Pharma, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 5.9 0.17 (2.88%) | --- | 0.0 (0.0%) | 0.06 (1.0%) | --- | 0.17 (2.88%) | --- | --- |
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.3
- Diluted EPS:
- -0.3
- Basic P/E:
- -20.2333
- Diluted P/E:
- -20.2333
- RSI(14) 1m:
- 100.0
- VWAP:
- 6.07
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Nov 05, 2024 12:00
Aug 29, 2024 12:00
May 24, 2024 13:55
May 16, 2024 12:30
May 07, 2024 12:00
Apr 08, 2024 12:30
Mar 19, 2024 12:00
Mar 15, 2024 12:00
Mar 05, 2024 13:00